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Background. In 1987, three unrelated English families were reported with a putative blood subgroup 
called Apae. Swedish researchers later found evidence leading to abolishment of the Apae subgroup and 
establishment instead of the FORS blood group system (System 31 - ISBT, 2012). It is important to 
know the prevalence of antibodies in order to make the best decisions in transfusion medicine. Cells 
expressing the Forssman saccharide, such as sheep erythrocytes, are needed to detect the anti-Forssman 
antibody. The aim of this study was to define the prevalence of human anti-Forssman antibody.
Materials and methods. Plasma samples from 800 individuals were studied. Sheep erythrocytes or 
Forssman "kodecytes" were mixed with the plasma samples using the tube technique. Plasma from an 
Apae individual was used as a negative control and monoclonal anti-Forssman antibody (M1/22.25.8HL 
cell line supernatant) was used as the positive control.
Results. Of the 800 individuals tested, one was negative for the presence of anti-Forssman antibody. 
We compared the anti-Forssman antibody reaction pattern between genders and found that males have 
weaker reactions than females, both at room temperature (p=0.026) and at 37 °C (p=0.043). We also 
investigated the reaction pattern of anti-Forssman antibody in relation to ABO and Rh blood group 
types without finding any significant differences.
Discussion. Sheep erythrocytes are suitable for searching for human anti-Forssman antibody. The 
quantity of anti-Forssman antibodies in plasma is higher in females than in males. In the population 
(n=800) studied here, we found one individual lacking the anti-Forssman antibody. These results 
contribute to the data already published, confirming that FORS is a rare blood group.
Keywords: FORS blood group, human anti-Forssman, function-spacer-lipids constructs, ABO 
blood-group prevalence.
Introduction
In 1900, Karl Landsteiner discovered the existence 
of natural antibodies reacting with the red blood cells 
(RBC) of other human beings, which revealed the ABO 
blood group system1. The ABO blood group system 
is of great importance in transfusion/transplantation 
medicine1,2. The research and development of the 
human antiglobulin test by Coombs and Race led to 
other blood systems of major clinical significance 
being discovered2.
In 1911, Professor John Forssman found that 
injection of a suspension of kidney tissue from guinea 
pigs or horses into rabbits led to the production of an 
antibody capable of haemolysing sheep RBC, whereas 
injection of a suspension of kidney tissue from cows or 
rats did not produce antibodies. The antigen on the sheep 
RBC was named the Forssman (Fs) antigen3.
Species were divided into Fs-positive (sheep, dogs, 
horses, etc.) and Fs-negative species (rabbits, pigs, 
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initially recognised on sheep RBC, this antigen is rarely 
found on RBC, its expression being restricted only to 
tissues in many species3. Nevertheless, there are species 
that express the Fs antigen on both RBC and tissues, such 
as chicken, and others that express the antigen only on 
RBC, such as sheep3.
In 1987, members of three unrelated English families 
were reported to have a putative new subgroup of blood 
group A, called Apae
4,5. RBC from the Apae positive family 
members showed unusual antibody and lectin reaction 
patterns, with a strong reaction to Helix pomatia lectin, a 
weak reaction to some polyclonal anti-A antibodies and, 
strangely, no reaction to monoclonal anti-A antibody, 
thus leading to some controversy5,6.
According to a recent study, the Fs glycolipid 
(which had only been found on the RBC of non-primate 
mammals) was strongly expressed on the RBC from 
individuals with subgroup Apae
4. The Swedish group that 
made this discovery were also able to demonstrate that 
the Fs glycolipid is transmitted hereditarily4.
The Fs antigen, like the A group antigen, terminates 
with an α3-N-acetylgalactosamine and is synthesised 
by Fs-synthase (encoded by the GBGT1 gene), which 
is not usually active in humans4,7,8 3-N-acetylgalactosa
minyltransferase; EC 2.4.1.88. However, Yamamoto et 
al. found that reversion of two inactivating missense 
mutations in the human GBGT1 gene (c.688G>A 
[p.Gly230Ser] and c.887A>G [p.Gln296Arg]) fully 
restored glycosyltransferase activity allowing the 
synthesis of Fs antigen in vitro8. These glycine and 
glutamine residues are conserved among functional 
GBGT1 genes in Fs-positive species8. 
In brief, Svensson et al. provided evidence leading 
to the conclusion that subgroup Apae should be abolished 
and a new histo-blood group should be created, the FORS 
blood group system4, which, in 2012, was accepted by 
the International Society of Blood Transfusion as the 31st 
blood group system. This system could have important 
implications in transfusion/transplantation medicine.
The Fs antigen is present in several forms of human 
cancer, including gastric, colon, and lung cancers9,10. 
Ono et al. demonstrated the presence of Fs antigen in 
the cytoplasm of colon goblet cells, especially those in 
the so-called transitional mucosa adjacent to carcinoma, 
from 69 of 70 patients with colon cancer9. Using 
chemical and immunological methods of detection it 
was confirmed that the Fs antigen is absent from healthy 
tissues of individuals with Fs-positive tumours, making 
this antigen an interesting candidate for targeted cancer 
therapy10.
With regards to transfusion/transplantation medicine, 
it is important to know the prevalence of an antibody 
when making decisions. In order to determine the 
prevalence of the anti-Fs antibody, cross-reactions must 
be performed between RBC containing the Fs saccharide 
and plasma samples.
Nowadays, it is possible to modify the membranes 
of RBC for such studies, or modify a solid phase, 
using function-spacer-lipid (FSL) constructs (KODETM 
technology)6,11-14. This technology allows us to modify 
various biosurfaces with bioactives products, within 
a couple of hours and with a relative simple protocol, 
without affecting cell viability and functionality6,11,12.
The aim of this study was to determine the prevalence 
of anti-Fs antibodies in plasma samples from humans, 
thereby contributing data to strengthen the classification 
of the FORS blood group as a new histo-blood group.
Materials and methods
"Kodecyte" production
"Kodecytes" were produced as described by Frame 
et al.11. RBC were incubated with a sugar suspension 
(FSL - KODE Biotech Limited, Auckland, New Zealand) 
to modify the RBC membrane. Type O RBC were 
washed six times with isotonic saline. Next, one part of 
the O RBC was incubated with two parts of 50 μg/mL 
Forssman pentasaccharide (FSL-Fs penta) modification 
solution. This solution was incubated for 2 hours at 
37 °C, with occasional mixing, and then transferred 
for overnight incubation at 4 °C. The modified cells 
("kodecytes") were washed six times and suspended 
in phosphate-buffered saline (137 mM NaCl, 2.7 mM 









to obtain a 0.8% working solution. Each batch of 
"kodecytes" was tested, weekly, by cross-reacting it with 
anti-Fs antibody (M1/22.25.8HL cell line supernatant) 
and 1:100 Helix pomatia, as a positive control, and the 
original O RBC as the negative control, in NaCl and 
Coombs' gel cards (DiaMed, Cressier, Switzerland).
Sheep red blood cell preparation
Ovis aries ibericus RBC, collected at Coimbra 
College of Agriculture, were washed six times and 
suspended in phosphate-buffered saline to make a 0.8% 
solution. Plasma from an Apae individual was used as a 
negative control and anti-Fs antibody (M1/22.25.8HL 
cell line supernatant) was used as the positive control.
Gel card haemagglutination 
The gel card haemagglutination tests were prepared 
by introducing 50 μL of 0.8% "kodecyte" solution or 
sheep RBC to wells containing NaCl and Coombs' gel 
cards and then adding 25 μL of each plasma sample 
to be tested. The gel cards were incubated for 15 
minutes at room temperature or 37 °C (ID-Incubator 
37 SI, DiaMed). After incubation, the gel cards were 
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All reactions were tested in duplicate, one at room 
temperature and the other at 37 °C. An aliquot of 
100 μL from each plasma sample was pipetted into 
the respective tubes and 50 μL of 0.8% sheep RBC 
suspension were added. The tubes were incubated for 
1 hour at room temperature or 37 °C (ID-Incubator 37 
SI, DiaMed). After the incubation the tubes were gently 
tapped and the results were read under an agglutinoscope 
(J.P. Selecta S.A., Barcelona, Spain). Agglutination was 
graded according to standard blood banking practice 
where 4+ is the strongest, 3+, 2+ and 1+ are gradually 
weaker but positive reactions, and 0 is negative.
Samples
We studied a total of 800 plasma samples of which 
468 (58.5%) were from Portugal, 206 (25.75%) from 
Palestine, and the remaining 126 (15,75%) from Sweden 
(Figure 1A).
Tube haemagglutination was used as the gold-
standard method, while gel card haemagglutination was 
used to confirm results. Informed consent was obtained 
according to the Helsinki Declaration.
Statistical analysis
The statistical programme IBM SPSS® 246 v.19 
(National Opinion Research Center, Chicago, USA) was 
used for the statistical computations. 
We applied the chi-square test to compare anti-Fs 
antibody reaction patterns according to gender and ABO 
and Rh blood groups, and the paired samples t-test to 
compare reaction patterns for tests carried out at room 
temperature and 37 °C for each sample.
Results
The studied population consisted of 437 males 
(55%) and 363 females (45%), with an average age of 
35 years (standard deviation, 15 years) (Figure 1B). 
Regarding the ABO blood group distribution, 69% 
of the samples were A Rh positive or O Rh positive. 
B Rh negative, AB Rh positive and AB Rh negative 
blood types accounted for 7% of the total samples 
(Figure 2).
The Portuguese samples came from 257 males 
(55%) and 211 females (45%), with an average age of 
40 years (standard deviation, 14 years) (Figure 3). In 
this subset of sample, 72% of the samples were A Rh 
positive or O Rh positive. B Rh negative, AB Rh positive 
and AB Rh negative blood types accounted for 5% of 
the Portuguese samples.
Samples from Palestine were donated by 106 males 
(51%) and 100 females (49%), with an average age 
of 21 years (standard deviation, 2 years) (Figure 3). 
Of these samples, 66% were A Rh positive or O Rh 
positive, while B Rh negative, AB Rh positive and 
AB Rh negative blood types accounted for 12% of the 
Palestinian samples analysed.
Finally, the samples from the Swedish population 
came from 74 males (59%) and 52 females (41%), with 
an average age of 44 years (standard deviation, 14 years) 
(Figure 3). Regarding ABO blood group distribution, 
64% of the samples were A Rh positive or O Rh positive. 
The B Rh negative, AB Rh positive and AB Rh negative 
blood types formed 6% of the Swedish samples.
Regarding the ABO and Rh blood type distribution 
we did not observe significant differences between the 
samples from Portugal, Palestine and Sweden.
Figure 1 - (A) The distribution of anti-Forssman antibody in the sample studied, divided according to country. (B) The 
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The prevalence of anti-Fs antibody in the 800 
samples studied was 99.88%, with only one sample 
(Portuguese) negative in both screening tests, namely 
at room temperature and at 37 °C (Figure 1A). 
We first compared the anti-Fs antibody reaction 
pattern between genders and found that males have 
weaker reaction (1+ and 2+) than females (3+, 4+ and 
visible [V]) both at room temperature (p=0.026) and 
at 37 °C (p=0.043) (Figure 4). We then compared the 
reaction patterns of anti-Fs antibody according to ABO 
and Rh blood groups, without finding any significant 
differences.
In order to characterise the anti-Fs antibody better, 
we compared the reaction pattern between the screening 
at room temperature and 37 °C for each sample. No 
significant differences were found (Figure 5).
Figure 2 - The distribution of ABO and Rh blood groups in 
the sample studied. 
Figure 3 - The distribution of age of the blood donors of the 
sample studied, divided by country. 
 Statistical significance is expressed by ***p<0.001.
Discussion
The prevalences of ABO blood group subtypes in this 
study were similar to those in previous studies15,16 included 
14,916 (13,691 retrospective and 1,225 prospective). 
Regarding the age of each population we observed that 
the cohorts from Sweden and Portugal were older, while 
in Palestine the maximum age was 37 years, with this 
being a statistically significant younger population (Figure 
4). This is explained by the fact that all the Palestinian 
samples came from university students.
Svensson et al. described the new blood group 
system, FORS, as rare in humans4. Our prevalence data 
on the anti-Fs antibody confirm that the FORS system is 
a rare blood group system. However, while the literature 
describes only three unrelated English families with 
the FORS system, it is possible that we have found a 
Portuguese person with this rare blood group, given the 
individual's lack of anti-Fs antibody.
Nevertheless, there are various possible explanations 
for the absence of anti-Fs antibody in an individual. 
First, some individuals may not be able to synthesise 
anti-Fs antibody, as their immune response against 
Fs antigen could be under genetic control. Second, 
anti-Fs antibody might be produced in all people, but 
could be absorbed onto some normal or cancerous 
tissues containing the Fs antigen. Alternatively, Fs 
antigen could be shed from tissues resulting in the 
formation of anti-Fs-Fs immune complexes17. Third, 
some individuals could have very low anti-Fs antibody 
titres which could be below the level of detection of 
the assaying method used.
We found that females had statistically significant 
more anti-Fs antibodies than had males (Figure 4). 
However, the reaction pattern of this antibody does 
not seem to be affected by either ABO or Rh group. 
Likewise, the different reaction pattern of the anti-Fs 
antibody at room temperature and at 37 °C was not 
statistically significant (Figure 5).
There are several possible explanations for the larger 
amount of anti-Fs antibody in women, including the 
fact that women, in general, have a stronger immune 
system and responses than men. This gender diversity 
is believed to be controlled by differences in the blood 
levels of gonadal steroid hormones, including the 
female hormone, oestrogen, which stimulates immune 
responses, and the male hormone, testosterone, which 
has an immunosuppressive effect18.
In this study we have demonstrated and described 
new strategies for the search of the human anti-Fs Ab, 
using FLS constructs ("kodecytes") and sheep RBC.
Conclusions
We can conclude that the prevalence of anti-Fs 
antibody is high in humans, since we found only one 
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Figure 4 - Comparison of anti-Forssman antibody reactions between genders (male, – continuous line; female, - - dashed line): 
(A) at room temperature and (B) at 37 °C.
Figure 5 -  Comparison of the frequency of anti-Forssman antibody reactions at room temperature (R.T.) and at 37 °C.
published that FORS is a rare blood group system. Anti-
Fs antibody is not affected by ABO or Rh blood group 
and is present at higher concentrations in females than 
in males. Sheep RBC and "kodecytes" can be used to 
screen for human anti-Fs.
As future perspectives, it will be interesting to study 
the RBC of the donor who lacked the anti-Fs antibody 
and his family in order to clarify whether they are FORS 
antigen-positive and the impact of these antibodies in 
transfusion medicine.
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